HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells.

Abstract
Vascular smooth muscle cell (VSMC) hypertrophy is believed to play some roles in atherosclerosis. To elucidate the role of vascular D1-like receptors in VSMC hypertrophy, the effects of dopamine and specific D1-like receptor agonists SKF 38393 and YM 435 on platelet-derived growth factor (PDGF) BB-mediated VSMC hypertrophy was studied. We observed that cells stimulated by PDGF-BB 5 ng/mL showed increased VSMC hypertrophy. These effects were prevented by coincubation with dopamine, SKF 38393, and YM 435 1-10 mumol/L, and this prevention was reversed by Sch 23390 1 to 10 mumol/L, a specific D1-like receptor antagonist. These actions are mimicked by forskolin 1 to 10 mumol/L, a direct activator of adenylate cyclase and 8-bromo-cAMP 0.1 to 1 mmol/L, and are blocked by a specific protein kinase A (PKA) inhibitor N-[2-(P-bromcoinnamylamino)ethyl]-5-isoquinoline-sulfonamide (H89) but not blocked by its negative control. PDGF-BB (5 ng/mL)-mediated mitogen-activated protein kinase (MAPK) activity was significantly suppressed by coincubation with D1-like receptor agonists, which were reversed by PKA inhibitor H 89. These results suggest that vascular D1-like receptor agonists inhibit hypertrophy of VSMC, possibly through PKA activation and suppression of activated MAPK activity.
AuthorsK Yasunari, M Kohno, H Kano, K Yokokawa, M Minami, J Yoshikawa
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 29 Issue 1 Pt 2 Pg. 350-5 (Jan 1997) ISSN: 0194-911X [Print] United States
PMID9039126 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzazepines
  • Dopamine Antagonists
  • Isoquinolines
  • Platelet-Derived Growth Factor
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-sis
  • Receptors, Dopamine D1
  • Sulfonamides
  • Tetrahydroisoquinolines
  • Becaplermin
  • Colforsin
  • 8-Bromo Cyclic Adenosine Monophosphate
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • zelandopam
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
Topics
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine (pharmacology)
  • 8-Bromo Cyclic Adenosine Monophosphate (pharmacology)
  • Animals
  • Becaplermin
  • Benzazepines (pharmacology)
  • Cells, Cultured
  • Colforsin (pharmacology)
  • Dopamine Antagonists (pharmacology)
  • Hypertrophy (prevention & control)
  • Isoquinolines (pharmacology)
  • Muscle, Smooth, Vascular (drug effects, pathology)
  • Platelet-Derived Growth Factor (antagonists & inhibitors, pharmacology)
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-sis
  • Rats
  • Receptors, Dopamine D1 (agonists, drug effects)
  • Renal Artery
  • Sulfonamides
  • Tetrahydroisoquinolines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: